Background and Purpose Brain dopamine has been implicated as a mediator of brain neuronal damage resulting from ischemic injury. Augmented interleukin-1 production and cerebral ischemia occurred during onset of heatstroke. This study has attempted to ascertain whether heatstroke resulting from hyperthermia causes an increase in hypothalamic dopamine release and to assess whether the administration of an interleukin-1 receptor antagonist (IL-lra) can attenuate heatstroke formation.
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Background and Purpose Brain dopamine has been implicated as a mediator of brain neuronal damage resulting from ischemic injury. Augmented interleukin-1 production and cerebral ischemia occurred during onset of heatstroke. This study has attempted to ascertain whether heatstroke resulting from hyperthermia causes an increase in hypothalamic dopamine release and to assess whether the administration of an interleukin-1 receptor antagonist (IL-lra) can attenuate heatstroke formation.
Methods Both local cerebral blood flow and hypothalamic dopamine release during onset of heatstroke were assessed in saline-treated rats and in rats treated with an IL-lra. Heatstroke was induced by exposing the animals to a high ambient temperature. Hypothalamic dopamine release was determined by carbon fiber electrodes combined with in vivo differential pulse amperometry.
Results During onset of heatstroke, rats with heatstroke displayed higher values of colonic temperature, higher values T he pathophysiology of heatstroke has been studied extensively by investigators of different disciplines. 1 Our previous studies 24 demonstrated that the central nervous system dysfunction during onset of heatstroke was related to circulatory alterations, including systemic hypotension, intracranial hypertension, decreased cerebral perfusion, and cerebral ischemia. Other lines of evidence also suggested that marked activation of dopaminergic activity in the brain was observed after transient cerebral ischemia. 57 This raises the possibility that the dopaminergic activity in the brain is related to local cerebral blood flow and/or heatstroke formation.
In the present study, we examined the possible alteration of both dopamine release in the hypothalamus and blood flow in different brain regions in rats during onset of heatstroke. We also compared the temporal profile of hypothalamic dopamine release and local cerebral blood flow alteration in rats with heatstroke with and without administration of interleukin-1 receptor antagonist (IL-lra) before onset of heatstroke. Interleukin-1 (IL-1) production has been found to be augmented during onset of heatstroke in rabbits.
of hypothalamic dopamine release, and lower values of blood flow in different brain regions compared with normothermic control rats. In another separate experiment in which IL-lra (200 Mg/kg IV) was injected 30 minutes before onset of heatstroke, both the augmented hypothalamic dopamine release and diminished cerebral blood flow during onset of heatstroke were significantly attenuated. In addition, the survival time (interval between onset of heatstroke and death) of the rats with heatstroke was prolonged by pretreatment with IL-lra.
Conclusions These results suggest that an increase in hypothalamic dopamine release and a decrease in local cerebral blood flow occur during onset of heatstroke. Pretreatment with IL-lra attenuates the heatstroke formation resulting from cerebral ischemia by reducing hypothalamic dopamine release. 
Subjects and Methods Materials
IL-lra, used in the present study, was a gift from Dr James L. Vannice (SYNERGEN). This protein was expressed in Escherichia coli using a cDNA originally isolated from adherent monocytes. 9 IL-lra is the nonglycosylated, N-terminal methionyl form of the naturally occurring protein and has a molecular weight of approximately 17 kD. IL-lra blocks binding of IL-1 as well as the naturally occurring, glycosylated form does.
Animal Surgery and Measurement of Physiological Parameters
The right femoral artery and vein of adult male SpragueDawley rats (weighing between 250 and 300 g), under urethane (1.4 g/kg IP) anesthesia, were cannulated with polyethylene tubing (PE 50). Systemic arterial blood pressure was monitored continuously with a pressure transducer and a chart recorder (Gould model 481). The animals were then fixed to a stereotaxic frame. Colonic temperature was monitored continuously by thermocouples. The levels of extracellular dopamine-like materials in the right hypothalamus were recorded continuously with a Biopulse voltammeter (Solea Tacussel Co), as we previously reported. 10 ' 11 In brief, a carbon fiber electrode was used as a working electrode to measure the oxidation current of dopamine and was inserted into the right hypothalamus using the coordinates of A, 7.0 mm; L, 0.8 mm; H, -1.0 mm. 12 After conclusion of the experiments, 4-mA anodal DC was passed through the working electrodes for 10 seconds. The lesions induced in this way were used to identify the actual electrode site. A platinum wire and an Ag/AgCI wire used as auxiliary and reference electrodes, respectively, were placed on the dural surface in the frontal region and, with the plug connected to them, were fixed to the skull with dental cement. These electrodes were calibrated with various dopamine concentrations under 37°C phosphate buffer solution in a water bath with stirring. Before implantation, the electrodes also were calibrated in a 200-nmol/L dopamine standard solution. The concentration of extracellular dopamine in the right hypothalamus was measured from the amplitude of the voltammogram and was converted to nanomoles per liter compared with the concentration of standard dopamine used for calibration. ANOVA and unpaired Student's t test were applied to the mean values from separate experiments.
Measurement of Local Cerebral Blood Flow
The procedure for measuring local cerebral blood flow was similar to those used previously. 13 In rats, approximately 50 H-Ci of iodo [ 14 C]antipyrine in 1 mL of normal saline was infused at a constant rate through the femoral venous catheter for 1 minute, during which time arterial samples were collected on filter paper disks for assay of arterial concentration. At exactly 1 minute, the animal was decapitated, and the brain was removed, frozen, and assayed for I4 C concentration by the autoradiographic technique. Autoradiographs of sections of rat brain and calibrated plastic 14 C standards were used to determine tissue concentrations of 14 C by densitometric measurements.
Induction of Heatstroke
Three groups of animals were used.
(1) Rats with heatstroke received saline treatment: heatstroke was induced by exposing the rats, under urethane anesthesia, to an ambient temperature of 42°C. The movement in which mean arterial blood pressure began to decrease from its peak level was taken as onset of heatstroke, as shown in the Figure. The animals were given an intravenous dose of 1 mL/kg of 0.9% saline per 1 kg body weight 30 minutes before the onset of heatstroke. (2) Rats with heatstroke that received IL-Ira treatment: the rats, under urethane anesthesia, were given an intravenous dose of 200 mg/mL of IL-Ira per 1 kg body weight 30 minutes before onset of heatstroke. (3) Normothermic control rats: the rats, under urethane anesthesia, were exposed to an ambient temperature of 24°C for at least 90 minutes. Then they were given an intravenous dose of 1 mL/kg of 0.9% saline 30 minutes before death for cerebral blood flow assay. Their colonic temperatures were kept at about 37°C by an electric thermal mat. Table 1 summarizes the mean and SEM values for each measurement of the various parameters collected from two groups of animals. Heatstroke was induced by exposing the animals to an ambient temperature of 42°C. The latency of onset of heatstroke was found to be 60 minutes for all these animals. As Table 1 shows, rats that received saline injection 30 minutes before onset of heatstroke displayed higher values of colonic temperature, lower values of mean arterial blood pressure, and higher values of dopamine release in the hypothalamus compared with their preinjection controls. val between onset of heatstroke and death) of the rats with heatstroke. Both the arterial hypotension and the augmented release of hypothalamic dopamine during onset of heatstroke were attenuated after pretreatment with IL-lra. In addition, the hyperthermia just before death was significantly reduced after IL-lra pretreatment. The Figure depicts a effects of IL-lra on colonic temperature, arterial blood pressure, hypothalamic dopamine release, and survival time. Table 2 summarizes the mean and SEM values for blood flow in 10 structural components of the normothermic control rat brain obtained with iodo[ 14 C]antipyrine and compares them with the values obtained in paired animals during onset of heatstroke. The values obtained from animals suffering from heatstroke were significantly lower than those obtained from normothermic control rats in all structures. The table also shows that the reduced local cerebral blood flow values in all structural components of the brains from rats with heatstroke were restored to normal levels by pretreatment of animals with IL-lra 30 minutes before onset of heatstroke.
Results

Discussion
Our previous results 24 demonstrated that during onset of heatstroke animals displayed hyperthermia, systemic hypotension, intracranial hypertension, decreased cerebral perfusion, cerebral ischemia, and degeneration of neurons in different brain regions, including the hypothalamus and corpus striatum. During the fever plateau, however, the febrile animals did not show the above-mentioned physiological dysfunction and brain neuronal loss, although they had similar levels of hyperthermia. 23 These observations suggested that cerebral ischemia or anoxia was the main cause for development of heatstroke syndromes (in particular, the central nervous system dysfunctions). The present results, obtained with the in vivo voltametry, demonstrated that during onset of heatstroke a massive amount of dopamine was released into the extracellular fluid compartment of rat hypothalamus, and blood flow in the hypothalamus and other brain regions was reduced significantly. In fact, it has been concluded that dopaminergic hyperactivity is necessary for cell death in brain during cerebral ischemia or anoxia.
14 The ischemic damage to brain neurons was reduced by depleting the brain dopamine concentration with intracerebroventricular injection of 6-hydroxydopamine. 15 As Graham 16 suggested, sustained auto-oxidation of dopamine could lead to excessive accumulation of toxic quinones and potentially cytotoxic oxygen free radicals. These observations prompted us to think that the dopaminergic hyperactivity in the brain is responsible for the selective vulnerability of brain neurons to cerebral ischemia during onset of heatstroke. The dopaminergic hyperactivity was proposed to contribute to selective vulnerability of cerebral neurons to ischemic injury either by accentuation of postischemic hypoperfusion or by a direct metabolic effect. 5 Some experimental evidence suggests that pyrogens of intestinal origin play a role in heatstroke formation. At least in experimental animals, immunization against bacterial endotoxin 17 or administration of antibiotics before heating sharply reduces mortality. 18 Our recent results 8 also showed that during onset of heatstroke rabbits displayed augmented IL-1/3 production (in both the plasma and the hypothalamus) compared with that of normothermic control rabbits. In addition, the present results showed that the animals with heatstroke that received an intravenous injection of IL-lra had a survival time longer than the animals with heatstroke that received control-vehicle solution. Could the fact that the IL-lra merely prolonged survival time but did not reduce mortality be a result of the short half-life of IL-lra? Would additional injections of IL-lra reduce mortality? These questions must be answered by further studies in the near future. Furthermore, in our experiments in which IL-lra was intravenously injected 30 minutes before onset of heatstroke, both the extracellular dopamine levels in the hypothalamus and local cerebral blood flow were restored to control levels. These results suggest that IL-lra attenuates heatstroke formation resulting from cerebral ischemia or anoxia by reducing the hypothalamic extracellular dopamine release in rats. However, the attenuation of heatstroke by IL-lra could be caused by some effect other than a reduction in dopamine release. For example, the brain temperature in the control animals where dopamine is the highest is 42.3°C, whereas in the IL-lra-treated animals the brain temperature just before death was 36.4°C. This substantial difference in brain temperature could have been the cause of the reduced release of dopamine. It should be mentioned that other interleukins, such as TNF-8 and IL-6, may play a role in heatstroke.
In a recent study, 19 in vivo voltametry was used in rats with transient cerebral ischemia by temporary clipping of the right common carotid artery, systemic hypotension, and intracranial hypertension to measure changes in extracellular dopamine concentrations in the corpus striatum. Striatal neuronal damage was also rated on a scale of 0 to 3 (0, no damage; 3, maximum cell loss). It was found that striatal dopamine levels increased by 12-fold and that striatal neuronal damage rated 2.5 during 30 minutes of brain ischemia. The dopamine levels returned to control levels 30 minutes after reperfusion. In a separate experiment in which 10% human albumin was intravenously infused 30 minutes before brain ischemia, both striatal dopamine levels and striatal neuronal damage were reduced compared with ischemic controls. These results suggest that hypervolemic hemodilution protects the striatal neurons from ischemic injury by reducing the extracellular dopamine release in the corpus striatum of rat brain. Hypervolemic hemodilution may have augmented cerebral blood flow by decreasing blood viscosity and rheological changes 20 - 21 and resulted in reduction of dopamine release. Therefore, we hypothesize that hypervolemic hemodilution may also protect against heatstroke formation from ischemic injury by reducing the extracellular dopamine release in the brain. Of course, this possibility needs to be verified by further studies.
